Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 24Recruiting 9Unknown 6Withdrawn 3Active not recruiting 2Terminated 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 3Other hematologic neoplasm 2Sarcoma 1Other 1Myeloid 1Lymphoid 1Gastrointestinal 1

Conditions

Breast Neoplasms 3

Interventions

Paclitaxel 31Cyclophosphamide 25Trastuzumab 23Doxorubicin 17Docetaxel 15Carboplatin 15pembrolizumab 13Radiotherapy 11Letrozole 11Capecitabine 11exemestane 10Fulvestrant 10Magnetic Resonance Spectroscopy 8Lapatinib 8Biopsy 8eribulin 7abemaciclib 7Taxes 7Bevacizumab 7Anastrozole 7pertuzumab 6palbociclib 6Neoadjuvant Therapy 6Goserelin 6Drug Therapy 6Aromatase Inhibitors 6130-nm albumin-bound paclitaxel 6Therapeutics 5Saline Solution 5Radiosurgery 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × High-Energy Shock Waves × Breast × Clear all
NCT05005936 2022-05-27

Comparing the Performance of Automated Breast Ultrasonography to Hand-Held Whole Breast Ultrasonography in Breast Cancer Treatment Response Assessment

M.D. Anderson Cancer Center

Withdrawn
Breast

Breast Neoplasms

NCT00722683 2017-10-18

Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts

University of Michigan

Phase NA Withdrawn
Breast

Breast Neoplasms

NCT01681901 2017-04-13

Ultrasound in Detecting Lymph Node Metastasis in Older Patients Undergoing Breast Sonography

Ohio State University Comprehensive Cancer Center

Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡